Literature DB >> 33760277

Will AstraZeneca be able to provide clinical trial data on its COVID-19 vaccine efficacy in older adults?

Rafael Dal-Ré1.   

Abstract

Entities:  

Keywords:  AstraZeneca vaccine; COVID-19; SARS-CoV-2; efficacy; elderly; placebo-controlled trials

Year:  2021        PMID: 33760277     DOI: 10.1111/bcp.14828

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans.

Authors:  Rafael Dal-Ré
Journal:  Therapie       Date:  2022-07-13       Impact factor: 3.367

2.  Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.

Authors:  Rafael Dal-Ré; Odile Launay
Journal:  Vaccine       Date:  2021-06-04       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.